Viewing Study NCT05925504


Ignite Creation Date: 2025-12-24 @ 9:10 PM
Ignite Modification Date: 2026-01-07 @ 7:11 AM
Study NCT ID: NCT05925504
Status: RECRUITING
Last Update Posted: 2024-03-12
First Post: 2023-06-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Tapering Dose of Luspatercept in Patients With Lower-risk Myelodysplastic Syndromes
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module